Abstract:Abstract Background Lung cancer has the highest case fatality rate among cancers because of uncontrolled proliferation and early metastasis of cancer cells in the lung tissue. This study aimed to clarify the role of the non-SMC condensin I complex, subunit G (NCAPG) in lung adenocarcinoma (LUAD), explore the mechanisms of its progression, and lay the foundation for the search for new biological markers. Methods We analyzed overlapping differentially expressed genes (DEGs) from three datasets; a protein–protein interaction (PPI) network was subsequently constructed and analyzed using Cytoscape. We then selected NCAPG for validation because of its poor prognosis and because it has not been sufficiently studied in the context of LUAD. Immunohistochemical analysis was used to detect the expression of NCAPG in LUAD tissues, and the relationships between NCAPG and clinical parameters were analyzed. In vitro and in vivo experiments were conducted to verify the role of NCAPG in LUAD. Finally, we studied the specific mechanism of action of NCAPG in LUAD. Results Through comprehensive analysis of the GSE43458, GSE75037, and The Cancer Genome Atlas databases, we identified 517 overlapping DEGs. Among them, NCAPG was identified as a hub gene. Immunohistochemical analysis revealed that NCAPG was strongly associated with the clinical stage, M-classification, and N-classification. Univariate and multivariate Cox regression analyses indicated that NCAPG was a prognostic risk factor for LUAD, while the in vitro experiments showed that NCAPG overexpression promoted proliferation, migration, invasion, and epithelial-mesenchymal transition. Furthermore, knockdown of NCAPG inhibited LUAD progression, both in vitro and in vivo. Mechanistically, NCAPG overexpression increased p-Smad2 and p-Smad3 expressions in the transforming growth factor β (TGF-β) signaling pathway. Additionally, rescue experiments indicated that TGF-β signaling pathway inhibitors could restore the effect of NCAPG overexpression in LUAD cells. Conclusions NCAPG may promote proliferation and migration via the TGF-β signaling pathway in LUAD.

Important role and underlying mechanism of non‐SMC condensin I complex subunit G in tumours (Review)

The role of NCAPG in various of tumors

Overexpression of Non-Smc Condensin I Complex Subunit G Serves As a Promising Prognostic Marker and Therapeutic Target for Hepatocellular Carcinoma

NCAPG2 Promotes Tumour Proliferation by Regulating G2/M Phase and Associates with Poor Prognosis in Lung Adenocarcinoma

MCM Family in Gastrointestinal Cancer and Other Malignancies: from Functional Characterization to Clinical Implication

NCAPG facilitates colorectal cancer cell proliferation, migration, invasion and epithelial–mesenchymal transition by activating the Wnt/β-catenin signaling pathway

Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer.

Targeting CDK7 in oncology: The avenue forward.

Nonstructural Maintenance of Chromatin Condensin I Complex Subunit G Promotes the Progression of Glioblastoma by Facilitating Poly (Adp-Ribose) Polymerase 1-Mediated E2F1 Transactivation

Non‐SMC condensin I complex subunit H participates in anti‐programmed cell death‐1 resistance of clear cell renal cell carcinomas

NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression

Multiple roles of p53 in cancer development: Regulation of tumor microenvironment, m6A modification and diverse cell death mechanisms

MCMs in Cancer: Prognostic Potential and Mechanisms

An Integrative Pan-Cancer Analysis Reveals the Carcinogenic Effects of NCAPH in Human Cancer.

Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer

The multifaceted role of micronuclei in tumour progression: A whole organism perspective.

NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway

Silencing non-SMC chromosome-associated polypeptide G inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells

FOXM1/lncRNA TYMSOS/miR-214-3p–Mediated High Expression of NCAPG Correlates With Poor Prognosis and Cell Proliferation in Non–Small Cell Lung Carcinoma

The Pivotal Oncogenic Role of Jab1/CSN5 and Its Therapeutic Implications in Human Cancer

NCAPG2 Overexpression Promotes Hepatocellular Carcinoma Proliferation and Metastasis Through Activating the STAT3 and NF-κB/miR-188-3p Pathways